XML 38 R23.htm IDEA: XBRL DOCUMENT v3.22.4
16. Restructuring Costs (Notes)
 12 Months Ended
Dec. 31, 2022
Restructuring Costs [Abstract]  
Restructuring and Related Activities Disclosure [Text Block] RESTRUCTURING COSTSIn February 2021, we announced our strategy-driven restructuring plan in furtherance of our ongoing program to improve operating performance. The restructuring plan primarily impacts our operations in EMEA and includes the elimination of certain positions, the consolidation of certain functions, and the relocation of certain manufacturing operations from EMEA to APAC. The restructuring plan is being implemented in phases and is expected to be substantially complete by mid-2023. The liability of $31.6 million as of December 31, 2022 consisted of $31.5 million recorded in Accrued payroll and employee benefits and $0.1 million recorded in Account payable in the consolidated balance sheets. The expense and adjustments to expense recorded were reflected in Cost of goods sold of $1.1 million and $25.0 million, in Selling, general and administrative expense of $3.0 million and $26.1 million and in Research and development expense of $0.1 million and $13.3 million in the consolidated statements of income (loss) for the years ended December 31, 2022 and December 31, 2021, respectively. The adjustments to expense recorded were primarily due to extension of termination dates for certain employees, changes in the estimates of employee termination benefits and employees resigning or transferring to different positions within the company. From February 2021 to December 31, 2022, total expenses were $68.6 million.
The following table summarizes the activity of our European reorganization restructuring reserves (in millions):
20222021
Life ScienceClinical DiagnosticsTotalLife ScienceClinical DiagnosticsTotal
Balances as of January 1$5.2 $41.9 $47.1 $— $— $— 
Charged to expense - employee termination benefits— — — 12.9 62.7 75.6 
Adjustment to expense1.1 3.1 4.2 (3.3)(7.9)(11.2)
Cash payments(4.1)(12.7)(16.8)(4.0)(10.2)(14.2)
Foreign currency adjustments(0.3)(2.6)(2.9)(0.4)(2.7)(3.1)
Balances as of December 31$1.9 $29.7 $31.6 $5.2 $41.9 $47.1